Parra, Rogério Serafim http://orcid.org/0000-0002-5566-9284
Chebli, Júlio Maria Fonseca
Queiroz, Natália Sousa Freitas
Damião, Aderson Omar Mourão Cintra
de Azevedo, Matheus Freitas Cardoso
Chebli, Liliana Andrade
Bertges, Erika Ruback
Alves Junior, Antonio José Tiburcio
Ambrogini Junior, Orlando
da Silva, Bianca Loyo Pona Schiavetti
Lubini, Marcio
Bafutto, Mauro
Flores, Cristina
Vilela, Eduardo Garcia
Boratto, Sandra Felice
Gasparetti Junior, Newton Luiz Tricarico
Steinwurz, Flavio
Carvalho, Nayara Salgado
Féres, Omar
da Rocha, José Joaquim Ribeiro
Article History
Received: 2 June 2021
Accepted: 12 April 2022
First Online: 21 April 2022
Declarations
:
: The need for informed consent to participate was waived by the ethics committee of the Hospital das Clínicas of the Ribeirão Preto Medical School, University of São Paulo (HCFMRP-USP) due to retrospective and anonymous nature of the study. The study was approved by the ethics committee of the coordinating site (HCFMRP-USP, CAAE: 13436419.7.1001.5440; Ethics Committee Number: 3.335.068/2019). All procedures were conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
: Parra RS has received fees for serving as a speaker and/or an advisory board member for AbbVie, Ferring Pharmaceuticals, Janssen, and Takeda. Chebli JMF has received fees for serving as a speaker and/or an advisory board member for Abbott, AbbVie, Janssen, and Takeda. Queiroz NSF reports receiving consulting and lecture fees from Janssen, Takeda, and Abbvie. Damiao AOMC has received fees for serving as a speaker and/or an advisory board member for Takeda, Abbvie, Pfizer, Janssen, Ferring, and Natulab. Azevedo MFC reports receiving consulting fees from Janssen, lecture fees from Janssen, Takeda, and Abbvie, and travel grant support from Takeda, Janssen, and Abbvie. Chebli LA has received fees for serving as a speaker for Janssen and Takeda. Alves Jr AJT received fees for serving as a speaker and/or an advisory board member for Janssen, Takeda, Abbvie, Nestle and Apsen. Ambrogini Jr O has received fees for serving as a speaker and/or an advisory board member for Janssen, Abbvie, Takeda, and UCB. Da Silva BLPS has received fees for serving as a speaker for Pfizer, Abbvie, Janssen, and Takeda. Flores C has received fees for serving as a speaker for Janssen, Abbvie, UCB Biopharma, and Takeda. Steinwurz F is speaker/consultant/researcher for Abbvie, Amgen, Ferring, Janssen, Novartis, Pfizer, Sandoz, Takeda, and UCB biopharma. Bertges ER, Lubini M, Bafutto M, Vilela EG, Boratto SDF, Gasparetti Jr NLT, Salgado NC, Féres O, and Rocha JJR report no conflict of interest.